Medtronic Accelerates Path to Artificial Pancreas
Tuesday, June 9, 2015
Source: Medical Design Technology
On June 6, 2015, as part of its commitment to developing an artificial pancreas for people with diabetes, Medtronic plc announced results from the European User Evaluation of the MiniMed 640G system, which demonstrated that the pump’s exclusive SmartGuard technology can reduce hypoglycemia (low blood glucose) and offer further advancement in automation compared to previous generation Medtronic insulin pump systems.
The results will be presented in a poster session at the American Diabetes Association 75th Scientific Sessions on Sunday, June 7 at 12:00pm in Hall B at the Boston Convention and Exhibition Center.